Progressive multifocal leukoencephalopathy: what's new? (Q37755922)

22 August 2017

1 reference

title

Progressive multifocal leukoencephalopathy: what's new? (English)

1 reference

progressive multifocal leukoencephalopathy

22 August 2017

0 references

Daniele Focosi

1

0 references

Fabrizio Maggi

object named as

Fabrizio Maggi

4

0 references

author name string

Tuccori Marco

2

1 reference

22 August 2017

Richard Eric Kast

3

1 reference

22 August 2017

Luca Ceccherini-Nelli

5

1 reference

22 August 2017

Mario Petrini

6

1 reference

22 August 2017

1 June 2010

1 reference

22 August 2017

1 reference

22 August 2017

16

1 reference

22 August 2017

308-323

1 reference

22 August 2017

3

1 reference

Review of progressive multifocal leukoencephalopathy and natalizumab

22 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Treatment of non-AIDS progressive multifocal leukoencephalopathy with cytosine arabinoside

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

The atypical antipsychotic agents ziprasidone [correction of zisprasidone], risperdone and olanzapine as treatment for and prophylaxis against progressive multifocal leukoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Clinical epidemiology and survival of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy: data from the Italian Registry Investigative Neuro AIDS (IRINA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Progressive multifocal leuko-encephalopathy; a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Detection of BK virus and JC virus DNA in urine samples from immunocompromised (HIV-infected) and immunocompetent (HIV-non-infected) patients using polymerase chain reaction and microplate hybridisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Progressive multifocal leukoencephalopathy and natalizumab--unforeseen consequences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Spinal cord lesions of progressive multifocal leukoencephalopathy in an acquired immunodeficiency syndrome patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Increased numbers of circulating hematopoietic stem/progenitor cells are chronically maintained in patients treated with the CD49d blocking antibody natalizumab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Remission of AIDS-associated progressive multifocal leukoencephalopathy after cidofovir therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Identification and characterization of mefloquine efficacy against JC virus in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Nonmyeloablative allogeneic stem cell transplantation for refractory Hodgkin's lymphoma complicated by interleukin-2 responsive progressive multifocal leukoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Rituximab and progressive multi-focal leukoencephalopathy: the jury is deliberating.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Mirtazapine use in human immunodeficiency virus-infected patients with progressive multifocal leukoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

HIV-2 diagnosis and quantification in high-risk patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Serotonin receptor 2A blocker (risperidone) has no effect on human polyomavirus JC infection of primary human fetal glial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Polyomavirus JC infects human brain microvascular endothelial cells independent of serotonin receptor 2A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Asymptomatic reactivation of JC virus in patients treated with natalizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

The Evolving Face of Human Immunodeficiency Virus-Related Progressive Multifocal Leukoencephalopathy: Defining a Consensus Terminology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

A prospective study of human polyomavirus infection in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Cytarabine treatment of progressive multifocal leukoencephalopathy. Clinical course and detection of virus-like particles after antiviral chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Response to cidofovir after failure of antiretroviral therapy alone in AIDS-associated progressive multifocal leukoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Decrease in the numbers of dendritic cells and CD4+ T cells in cerebral perivascular spaces due to natalizumab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Potential mechanisms of the human polyomavirus JC in neural oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

JC virus VP1 loop-specific polymorphisms are associated with favorable prognosis for progressive multifocal leukoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

A case study: the use of cidofovir for the management of progressive multifocal leukoencephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Productive infection of cerebellar granule cell neurons by JC virus in an HIV+ individual

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Direct correlation between sialic acid binding and infection of cells by two human polyomaviruses (JC virus and BK virus).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Identification and functional significance of N-glycosylation of the 5-ht5A receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

The human polyomavirus, JCV, uses serotonin receptors to infect cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Evidence of human polyomavirus BK and JC infection in normal brain tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Progressive multifocal leukoencephalopathy following rituximab treatment in a patient with rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Does contrast enhancement predict survival in progressive multifocal leukoencephalopathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Progressive multifocal leukoencephalopathy in a haploidentical stem cell transplant recipient: a clinical, neuroradiological and virological response after treatment with risperidone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Sialic acid moieties and 5-HT2a: two faces of the same receptor for JC virus?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Hypothesis: central nervous system delivery of cyclosporine A for therapy of progressive multifocal leukoencephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

JC virus DNA in healthy brain tissue: a challenge for progressive multifocal leukoencephalopathy diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

JC viremia and multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Polyomaviruses other than JCV are not detected in progressive multifocal leukoencephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

An unusual complication of immunosuppression in myasthenia gravis: progressive multifocal leukoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Cidofovir (vistide) in therapy of progressive multifocal leukoencephalopathy in AIDS. Review of the literature and report of 2 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Progressive multifocal leukoencephalopathy and CD4+ T-lymphocytopenia in a patient with Sjögren syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Progressive multifocal leukoencephalopathy in the United States, 1979-1994: increased mortality associated with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

The efficacy of nucleoside analogs against JC virus multiplication in a persistently infected human fetal brain cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Failure of cidofovir therapy in progressive multifocal leukoencephalopathy unrelated to human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Mapping the history and current situation of research on John Cunningham virus - a bibliometric analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Survival prolongation in HIV-associated progressive multifocal leukoencephalopathy treated with alpha-interferon: an observational study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Incidence of JC-virus replication after rituximab therapy in solid-organ transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Natalizumab treatment for multiple sclerosis: recommendations for patient selection and monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Detection of the archetypal regulatory region of JC virus from the tonsil tissue of patients with tonsillitis and tonsilar hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Progressive multifocal leukoencephalopathy with detection of JC virus in a patient with chronic lymphocytic leukemia parallel to onset of fludarabine therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Association of prolonged survival in HLA-A2+ progressive multifocal leukoencephalopathy patients with a CTL response specific for a commonly recognized JC virus epitope.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

JC virus granule cell neuronopathy: A novel clinical syndrome distinct from progressive multifocal leukoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Progressive multifocal leukoencephalopathy, efalizumab, and immunosuppression: a cautionary tale for dermatologists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

False negative PCR despite high levels of JC virus DNA in spinal fluid: Implications for diagnostic testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Progressive multifocal leukoencephalopathy in a patient treated with natalizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Progressive multifocal leukoencephalopathy as a complication of hepatitis C virus treatment in an HIV-negative patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Progressive multifocal leukoencephalopathy after natalizumab monotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

JC virus: an oncogenic virus in animals and humans?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

NFAT4 is required for JC virus infection of glial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

A pilot study of cidofovir for progressive multifocal leukoencephalopathy in AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Infectious Complications Associated with Alemtuzumab Use for Lymphoproliferative Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

An siRNA against JC virus (JCV) agnoprotein inhibits JCV infection in JCV-producing cells inoculated in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Progressive multifocal leukoencephalopathy in patients with rheumatic diseases: are patients with systemic lupus erythematosus at particular risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Identification and importance of N-glycosylation of the human 5-hydroxytryptamine3A receptor subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Measurement of viral sequences in cerebrospinal fluid of AIDS patients with cerebral white-matter lesions using polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Detection of JC virus in the brains of aged patients without progressive multifocal leukoencephalopathy by the polymerase chain reaction and Southern hybridization analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Progressive multifocal leukoencephalopathy - the importance of early diagnosis illustrated in four cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Inhibitory effect of serotonin antagonists on JC virus propagation in a carrier culture of human neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Pharmacological cdk inhibitor R-Roscovitine suppresses JC virus proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Detection of JC virus DNA fragments but not proteins in normal brain tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

JC virus enters human glial cells by clathrin-dependent receptor-mediated endocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Rearrangement patterns of JC virus noncoding control region from different biological samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Prevalence and patterns of polyomavirus urinary excretion in immunocompetent adults and children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Adenine arabinoside in the treatment of progressive multifocal leukoencephalopathy: Use of virus-containing cells in the urine to assess response to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Topotecan in the treatment of acquired immunodeficiency syndrome-related progressive multifocal leukoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Reversal of CSF positivity for JC virus genome by cidofovir in a patient with systemic lupus erythematosus and progressive multifocal leukoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Use of cidofovir in progressive multifocal leukoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Detection of CSF-specific oligoclonal antibodies to recombinant JC virus VP1 in patients with progressive multifocal leukoencephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Atypical PML leading to a diagnosis of common variable immunodeficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Successful outcome of progressive multifocal leukoencephalopathy with cytarabine and interferon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

BK and JC viruses in human immunodeficiency virus type 1-infected persons: prevalence, excretion, viremia, and viral regulatory regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Trans-activation of the JC virus late promoter by the tat protein of type 1 human immunodeficiency virus in glial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Atypical progressive multifocal leukoencephalopathy associated with an unusual JC polyomavirus mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Progressive multifocal leukoencephalopathy in a patient with Franklin disease and hypogammaglobulinemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Re: Rituximab maintenance for the treatment of patients with follicular lymphoma: systematic review and meta-analysis of randomized trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

The uninvited guest: JC virus infection of neurons in PML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

JCV-DNA and BKV-DNA in the CNS tissue and CSF of AIDS patients and normal subjects. Study of 41 cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Successful cidofovir therapy of progressive multifocal leukoencephalopathy preceding angioimmunoblastic T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Progressive multifocal leukoencephalopathy developing in advanced pulmonal sarcoidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Favourable outcome of progressive multifocal leucoencephalopathy in two patients with dermatomyositis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Treatment of progressive multifocal leukoencephalopathy associated with natalizumab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Human polyomaviruses and brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Fulminant JC virus encephalopathy with productive infection of cortical pyramidal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Progressive multifocal leukencephalopathy in patients on highly active antiretroviral therapy: survival and risk factors of death

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Comparison of PCR-amplified JC virus control region sequences from multiple brain regions in PML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Characterization of the VP1 loop mutations widespread among JC polyomavirus isolates associated with progressive multifocal leukoencephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

The monoclonal anti-VLA-4 antibody natalizumab mobilizes CD34+ hematopoietic progenitor cells in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

Polyoma-like virions in a human demyelinating disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

The relative contributions of HAART and alpha-interferon for therapy of progressive multifocal leukoencephalopathy in AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409356594

21 January 2018

Identifiers

DOI

10.1177/1073858409356594

1 reference

22 August 2017

1 reference